Mito-FLAG regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
Mito-FLAG regimen refers to a regimen consisting of mitoxantrone, fludarabine, cytarabine as bolus (B) or continuous infusion (CI) and granulocyte- colony stimulating factor (G-CSF) in patients with recurrent and refractory acute myeloid leukemia (AML).[1]
Regimen
MitoMitoxantrone
FLFludarabine
ACytarabine (AraC)
GGranulocyte- colony stimulating factor
Indications
- Recurrent and Refractory acute myeloid leukemia (AML)[1]
References
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
